It's All About-Juvenile Diabetes Research Foundation-Tulsa-Curing Type 1 Diabetes
Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin. We do not know what causes this auto-immune reaction. Type 1 diabetes is not linked to modifiable lifestyle factors. There is no cure and it cannot be prevented.
Type 1 diabetes:
– Occurs when the pancreas does not produce insulin
– Represents around 10% of all cases of diabetes and is one of the most common chronic childhood conditions
– Onset is usually abrupt and the symptoms obvious
– Symptoms can include excessive thirst and urination, unexplained weight loss, weakness and fatigue and blurred vision
– Is managed with insulin injections several times a day or the use of an insulin pump.
Tulsa offers a fabulous array of cultural amenities including the acclaimed Tulsa Ballet, Tulsa Opera, Tulsa Symphony Orchestra and other programs of the Tulsa Performing Arts Center. Theater-going opportunities abound around town and the music scene thrives with everything from country and western to indie rock and from local nightlife concerts to huge music festivals. Each year a multitude of festivals and events such as Tulsa International Mayfest, Tulsa Oktoberfest and the Oklahoma Scottish Festival celebrate Tulsa’s culture and heritage and add to the long list of things to do in Tulsa. Some other places are: Tam Bao Buddist Temple, Caravan Cattle Company, Tulsa Historical Society, McClain’s Lounge, Gray Snail Saloon, Philtower, BOK Center, Atlas Life Building, Cherry Street Farmer’s Market, The Campbell Lounge, Turkey Mountain Urban Wilderness Area, First Christian Church, Boston Avenue Methodist Church, The Colony, Oklahoma Jazz Hall of Fame. All Video Credits are listed here http://broadcaster.beazil.net/public/credits/youtube/videos/41578 The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To draw the conclusion, let’s identify the main points –
diabetes mellitus,become an advocate,hyperosmolar hyperglycemic nonketotic syndrome,Scientific,acetohexamide,The Automation to Simulate Pancreatic Insulin Response Trial,Lantus,diabetic ketoacidosis,Afrezza,join,gestational diabetes mellitus,adult-onset diabetes,diabetes death rate,Health Care Providers,diabetes risk assessment,impaired glucose tolerance,Accredited Charity,patient self-monitoring of blood glucose,IFG,noninsulin treated patients,Novolin N,Cost of insulin,Beta Cell Health and Survival,IDDM,Continuous glucose monitoring,Land of the Red Man,undiagnosed type 2 diabetes,Global Diabetes Research,GDM,Type 2 Diabetes,patient-driven care,MultiPepT1De,Grant Management Portal,diabetes prevention program,raise money,at-risk relatives,T1D burden,Pre- Diabetes,CDE,Team Research,dipeptidyl peptidase 4 inhibitors,Diabetes Complications,longer-acting sulfonylureas,Random Plasma Glucose Test,research,IGT,T1D,Insulin detemir,diabetes care concepts,insulin strength,JDRFCC,certified diabetes educator,Veterans Affairs Diabetes Trial,Boomer’s.